search URL:,https://patents.google.com/?assignee=BLUEBIRD+BIO+INC
id,title,assignee,inventor/author,priority date,filing/creation date,publication date,grant date,result link,representative figure link
EP-1581056-B1,Therapeutic retroviral vectors for gene therapy ,"Genetix Pharmaceuticals Inc., Massachusetts Institute Of Technology","Philippe Leboulch, Robert Pawliuk, Karen Westerman",2002-12-13,2003-12-11,2010-07-21,2010-07-21,https://patents.google.com/patent/EP1581056B1/en,https://patentimages.storage.googleapis.com/db/2c/52/4d47b36ed6e0e5/imgf0001.png
CA-2328404-C,Novel lentiviral packaging cells ,"Genetix Pharmaceuticals, Inc., Philippe Leboulch, Karen Westerman","Philippe Leboulch, Karen Westerman",1998-05-13,1999-05-13,2007-07-24,2007-07-24,https://patents.google.com/patent/CA2328404C/en,
US-2017226216-A1,Bcma chimeric antigen receptors ,"Bluebird Bio, Inc.","Richard Morgan, Kevin Friedman",2014-07-24,2015-07-23,2017-08-10,,https://patents.google.com/patent/US20170226216A1/en,https://patentimages.storage.googleapis.com/22/9c/49/c0e7862f210948/US20170226216A1-20170810-D00001.png
US-2007190030-A1,Method of treating arthritis using lentiviral vectors in gene therapy ,"Genetix Pharmaceuticals, Inc.","Robert Pawliuk, Philippe LeBoulch",2001-04-17,2006-08-30,2007-08-16,,https://patents.google.com/patent/US20070190030A1/en,https://patentimages.storage.googleapis.com/b4/30/37/a7b687d351a807/US20070190030A1-20070816-D00001.png
AU-2015269197-B2,Improved T cell compositions ,"Bluebird Bio, Inc.",Kevin FRIEDMAN,2014-06-06,2015-06-05,2018-10-04,2018-10-04,https://patents.google.com/patent/AU2015269197B2/en,
AU-2015249376-C1,Improved methods for manufacturing adoptive cell therapies ,"Bluebird Bio, Inc.","Kevin FRIEDMAN, Dawn MAIER, Richard Morgan",2014-04-25,2015-04-24,2018-06-14,2018-06-14,https://patents.google.com/patent/AU2015249376C1/en,
AU-2014296626-B2,Multipartite signaling proteins and uses thereof ,"Bluebird Bio, Inc.","Alexander ASTRAKHAN, Michael CERTO, Jordan JARJOUR",2013-07-29,2014-07-23,2019-03-07,2019-03-07,https://patents.google.com/patent/AU2014296626B2/en,
US-2009136521-A1,Method for Selectively Depleting Hypoxic Cells ,"Genetix Pharmaceuticals , Inc., Dana-Farber Cancer Institute , Inc.","Kalindi Parmar, Peter Mauch, Julian Down",2005-10-03,2006-09-29,2009-05-28,,https://patents.google.com/patent/US20090136521A1/en,https://patentimages.storage.googleapis.com/US20090136521A1/US20090136521A1-20090528-D00000.png
US-2003139333-A1,Methods and compositions for promoting angiogenesis ,"Genetix Pharmaceuticals, Inc.","Robert Pawliuk, Phillipe LeBoulch, Renhai Cao, Yihai Cao",2002-01-18,2002-07-19,2003-07-24,,https://patents.google.com/patent/US20030139333A1/en,https://patentimages.storage.googleapis.com/05/1b/5b/ba6fbd2a509e70/US20030139333A1-20030724-D00001.png
US-2018085444-A1,Bcma chimeric antigen receptors ,"Bluebird Bio, Inc.","Richard Morgan, Kevin Friedman",2014-12-12,2015-12-07,2018-03-29,,https://patents.google.com/patent/US20180085444A1/en,https://patentimages.storage.googleapis.com/f5/06/ab/b82e82a2fca1b0/US20180085444A1-20180329-D00001.png
US-2002034501-A1,Methods and compositions for promoting angiogenesis using monocytes ,"Robert Pawliuk, Leboulch Philippe","Robert Pawliuk, Philippe LeBoulch",2000-05-18,2001-05-18,2002-03-21,,https://patents.google.com/patent/US20020034501A1/en,
US-2005158712-A1,Methods for purifying viral particles for gene therapy ,"Genetix Pharmaceuticals, Inc.","Philippe LeBoulch, Sergei Aleshkov",2002-06-21,2004-12-17,2005-07-21,,https://patents.google.com/patent/US20050158712A1/en,
US-2003039636-A1,Novel self-inactivating (SIN) lentiviral vectors ,"Genetix Pharmaceuticals, Inc.","Philippe LeBoulch, Karen Westerman",2001-05-01,2002-05-01,2003-02-27,,https://patents.google.com/patent/US20030039636A1/en,https://patentimages.storage.googleapis.com/a8/dc/cf/02a32a7fe90d96/US20030039636A1-20030227-D00001.png
US-2015329640-A1,Chimeric antigen receptors and immune cells targeting b cell malignancies ,"Bluebird Bio, Inc.",Mitchell Howard Finer,2012-12-20,2013-12-13,2015-11-19,,https://patents.google.com/patent/US20150329640A1/en,https://patentimages.storage.googleapis.com/76/a4/1c/ae52c67975917e/US20150329640A1-20151119-D00001.png
US-2017051308-A1,Mnd promoter chimeric antigen receptors ,"Bluebird Bio, Inc.","Richard Morgan, Kevin Friedman, Byoung Ryu",2014-04-25,2015-04-24,2017-02-23,,https://patents.google.com/patent/US20170051308A1/en,https://patentimages.storage.googleapis.com/ad/f2/83/28dbac7f306f48/US20170051308A1-20170223-D00001.png
AU-2012315699-B2,Compounds for improved viral transduction ,"Bluebird Bio, Inc.","Abraham Isaac BASSAN, Garrett Collins HEFFNER",2011-09-30,2012-09-28,2017-08-17,2017-08-17,https://patents.google.com/patent/AU2012315699B2/en,
AU-1598599-A,Anti-angiogenic gene therapy vectors and their use in treating angiogenesis-related diseases ,"Genetix Pharmaceuticals, Inc., Massachusetts Institute Of Technology","Thomas Bachelot, Philippe Leboulch, Robert James Pawliuk",1997-11-20,1998-11-20,1999-06-15,,https://patents.google.com/patent/AU1598599A/en,
US-8858928-B2,Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy ,"Bluebird Bio, Inc.","Maria Joann Denaro, Mitchell Howard Finer, Gabor Veres, Julian Down",2011-06-10,2012-06-08,2014-10-14,2014-10-14,https://patents.google.com/patent/US8858928B2/en,https://patentimages.storage.googleapis.com/c5/42/22/0fea597c9f6bdf/US08858928-20141014-D00001.png
AU-2002247007-B2,Use of compositions containing PDGF-BB for promoting angiogenesis ,"Genetix Pharmaceuticals, Inc.","Renhai Cao, Yihai Cao, Philippe Leboulch, Robert Pawliuk",2001-01-26,2002-01-18,2006-12-07,2006-12-07,https://patents.google.com/patent/AU2002247007B2/en,
AU-2012267512-A1,Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy ,"Bluebird Bio, Inc.","Maria Joann Denaro, Mitchell Howard Finer, Gabor Veres",2011-06-10,2012-06-08,2014-01-23,,https://patents.google.com/patent/AU2012267512A1/en,
US-2002013261-A1,Methods and compositions for promoting angiogenesis using polyethylene glycol (PEG) polymers ,"Robert Pawliuk, Leboulch Philippe","Robert Pawliuk, Philippe LeBoulch",2000-05-18,2001-05-18,2002-01-31,,https://patents.google.com/patent/US20020013261A1/en,https://patentimages.storage.googleapis.com/1c/19/df/29f9bd3f484a13/US20020013261A1-20020131-D00001.png
US-2018147271-A1,Anti-ror1 chimeric antigen receptors ,"Bluebird Bio, Inc., Five Prime Therapeutics, Inc., Eureka Therapeutics, Inc.","Richard Morgan, Robert Sikorski, Brian Wong, Emma Masteller, Luis Borges, Cheng Liu, Yiyang Xu",2015-05-18,2016-05-17,2018-05-31,,https://patents.google.com/patent/US20180147271A1/en,https://patentimages.storage.googleapis.com/19/ce/dd/7bc6cd67b03787/US20180147271A1-20180531-D00000.png
US-2007072816-A1,Methods for inhibiting angiogenesis ,"Genetix Pharmaceuticals, Inc.","Yihai Cao, Renhai Cao, Robert Pawliuk, Philippe LeBoulch",2002-01-17,2006-04-11,2007-03-29,,https://patents.google.com/patent/US20070072816A1/en,https://patentimages.storage.googleapis.com/e8/7a/33/c7a2b2ec73a4cd/US20070072816A1-20070329-D00001.png
US-2015216903-A1,Compounds for improved viral transduction ,"Bluebird Bio, Inc.","Garrett Collins Heffner, Abraham Issac Bassan",2012-08-10,2013-08-09,2015-08-06,,https://patents.google.com/patent/US20150216903A1/en,https://patentimages.storage.googleapis.com/e7/2f/4f/454994f3427e13/US20150216903A1-20150806-D00001.png
US-2018094280-A1,Vector formulations ,"Bluebird Bio, Inc.","Robert H. KUTNER, Wesley GORMAN, Francis J. PIERCIEY, Jr.",2015-03-20,2016-03-18,2018-04-05,,https://patents.google.com/patent/US20180094280A1/en,https://patentimages.storage.googleapis.com/02/4a/5e/259ecc0ddd73cf/US20180094280A1-20180405-D00000.png
AU-2011377617-B2,Improved gene therapy methods ,"Bluebird Bio, Inc.","Yves Beuzard, Philippe Leboulch, Olivier NEGRE, Emmanuel Payen",2011-09-23,2011-09-23,2018-03-08,2018-03-08,https://patents.google.com/patent/AU2011377617B2/en,
US-2014199279-A1,Methods for enhancing the delivery of gene-transduced cells ,"Bluebird Bio, Inc.","Julian David Down, Philippe Louis Leboulch",2011-01-03,2011-12-27,2014-07-17,,https://patents.google.com/patent/US20140199279A1/en,https://patentimages.storage.googleapis.com/c4/d2/f9/63f4b81822c716/US20140199279A1-20140717-D00001.png
WO-2012170431-A2,Improved geneswitch systems ,"Bluebird Bio, Inc.",Robert H. KUTNER,2011-06-06,2012-06-05,2012-12-13,,https://patents.google.com/patent/WO2012170431A2/en,
US-2017049819-A1,Kappa/lambda chimeric antigen receptors ,"Bluebird Bio, Inc.","Kevin Friedman, Byoung Ryu",2014-04-25,2015-04-24,2017-02-23,,https://patents.google.com/patent/US20170049819A1/en,https://patentimages.storage.googleapis.com/cf/e8/83/0a60230cfc7558/US20170049819A1-20170223-D00001.png
KR-20180122405-A,Genome-editing immune effector cells ,"블루버드 바이오, 인코포레이티드.","조던 자르주르, 알렉산더 아스트라칸",2016-03-11,2017-03-10,2018-11-12,,https://patents.google.com/patent/KR20180122405A/en,https://patentimages.storage.googleapis.com/b1/10/84/3768881416be5d/pct00004.png
US-2019078059-A1,Vcn enhancer compositions and methods of using the same ,"Bluebird Bio, Inc.","Melissa Bonner, Olivier NEGRE, Christopher TIPPER",2016-02-12,2017-02-10,2019-03-14,,https://patents.google.com/patent/US20190078059A1/en,https://patentimages.storage.googleapis.com/6b/08/01/6348451bc5db54/US20190078059A1-20190314-D00000.png
KR-20180110112-A,VCN enhancer composition and method of use thereof ,"블루버드 바이오, 인코포레이티드.","멜리사 보그너, 올리비에 네그레",2016-02-12,2017-02-10,2018-10-08,,https://patents.google.com/patent/KR20180110112A/en,https://patentimages.storage.googleapis.com/0c/87/9d/f4049632d7b747/pct00002.png
US-2019085092-A1,Anti-sialyl tn chimeric antigen receptors ,"Bluebird Bio, Inc., Viromed Co., Ltd.","Richard Morgan, Kevin Friedman, Seung Shin Yu, Jae-Gyun Jeong, Jin-A Chae",2015-08-31,2016-08-30,2019-03-21,,https://patents.google.com/patent/US20190085092A1/en,https://patentimages.storage.googleapis.com/24/b0/d5/4ec0efbb36bec4/US20190085092A1-20190321-D00001.png
CA-3020330-A1,Chimeric antigen receptor t cell compositions ,"Bluebird Bio, Inc., Michael T. Certo, Wai-Hang LEUNG","Michael T. Certo, Wai-Hang LEUNG",2016-04-07,2017-04-07,2017-10-12,,https://patents.google.com/patent/CA3020330A1/en,
WO-2017156479-A1,Ror1 chimeric antigen receptors ,"Bluebird Bio, Inc.","Dominik Hinz, Ahmad TRAD, Vera MOLKENTHIN, Richard Morgan, Kevin FRIEDMAN",2016-03-11,2017-03-10,2017-09-14,,https://patents.google.com/patent/WO2017156479A1/en,
WO-2014015318-A1,Soluble compounds for improved gene therapy methods ,"Bluebird Bio, Inc.","Garrett Collins HEFFNER, Robert KUTNER",2012-07-19,2013-07-19,2014-01-23,,https://patents.google.com/patent/WO2014015318A1/en,
WO-2018049226-A1,"Pd-1 homing endonuclease variants, compositions, and methods of use ","Bluebird Bio, Inc.","Jasdeep MANN, Joel Gay, Jordan JARJOUR, Joy ZHANG",2016-09-08,2017-09-08,2018-03-15,,https://patents.google.com/patent/WO2018049226A1/en,
WO-2017040529-A1,Anti-sialyl tn chimeric antigen receptors ,"Bluebird Bio, Inc., Viromed Co., Ltd.","Richard Morgan, Kevin FRIEDMAN, Seung Shin Yu, Jae-Gyun Jeong, Jin-A CHAE",2015-08-31,2016-08-30,2017-03-09,,https://patents.google.com/patent/WO2017040529A1/en,
WO-2018148502-A1,Vcn enhancer compositions and methods of using the same ,"Bluebird Bio, Inc.","Iulia Diaconu, Geoffrey B. PARSONS",2017-02-10,2018-02-09,2018-08-16,,https://patents.google.com/patent/WO2018148502A1/en,
WO-2018035423-A1,Genome editing enhancers ,"Bluebird Bio, Inc.","Sasha ASTRAKHAN, Garrett C. HEFFNER",2016-08-19,2017-08-18,2018-02-22,,https://patents.google.com/patent/WO2018035423A1/en,
JP-2016129524-A,Improved gene therapy methods ,"ブルーバード バイオ， インコーポレイテッド, Bluebird Bio Inc, ブルーバード  バイオ，  インコーポレイテッド","ネグル オリヴィエ, Negre Oliver, ネグル オリヴィエ, ペイヤン エマニュエル, Payen Emmanuel, ペイヤン エマニュエル, ルブールシュ フィリップ, Leboulch Philippe, ルブールシュ フィリップ, ブザール イヴ, Beuzard Yves, ブザール イヴ",2016-04-19,2016-04-19,2016-07-21,,https://patents.google.com/patent/JP2016129524A/en,
AU-2014256388-A1,Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy ,"Bluebird Bio, Inc.","Maria Joann Denaro, Mitchell Howard Finer, Gabor Veres",2011-06-10,2014-10-31,2014-11-20,,https://patents.google.com/patent/AU2014256388A1/en,
WO-2018085690-A1,Anti-bcma car t cell compositions ,"Bluebird Bio, Inc.","Travis QUIGLEY, Robert Ross",2016-11-04,2017-11-03,2018-05-11,,https://patents.google.com/patent/WO2018085690A1/en,
WO-2018152325-A1,Donor repair templates multiplex genome editing ,"Bluebird Bio, Inc.","Baeckseung LEE, Alexander ASTRAKHAN",2017-02-15,2018-02-15,2018-08-23,,https://patents.google.com/patent/WO2018152325A1/en,
WO-2018183692-A1,Vectors and compositions for treating hemoglobinopathies ,"Bluebird Bio, Inc., Children's Medical Center Corporation","Gabor Veres, David A. Williams",2017-03-29,2018-03-29,2018-10-04,,https://patents.google.com/patent/WO2018183692A1/en,
WO-2018039333-A1,"Tim3 homing endonuclease variants, compositions, and methods of use ","Bluebird Bio, Inc.","Kyle HAVENS, Jordan JARJOUR",2016-08-23,2017-08-23,2018-03-01,,https://patents.google.com/patent/WO2018039333A1/en,
WO-2019070974-A1,"Pcsk9 endonuclease variants, compositions, and methods of use ","Bluebird Bio, Inc.","Jordan JARJOUR, Kyle HAVENS, Michael CERTO, Max ECHTERLING",2017-10-04,2018-10-04,2019-04-11,,https://patents.google.com/patent/WO2019070974A1/en,
WO-2018106807-A1,"Gene therapy for mucopolysaccharidosis, type i ","Bluebird Bio, Inc.","Kendrick A. GOSS, Geoffrey B. PARSONS",2016-12-06,2017-12-06,2018-06-14,,https://patents.google.com/patent/WO2018106807A1/en,
WO-2018106821-A1,"Gene therapy for mucopolysaccharidosis, type ii ","Bluebird Bio, Inc.","Kendrick A. GOSS, Geoffrey B. PARSONS",2016-12-06,2017-12-06,2018-06-14,,https://patents.google.com/patent/WO2018106821A1/en,
WO-2017180993-A1,Salvage chimeric antigen receptor systems ,"Bluebird Bio, Inc.",Wai-Hang LEUNG,2016-04-14,2017-04-14,2017-10-19,,https://patents.google.com/patent/WO2017180993A1/en,
EP-3487994-A1,"Bcl11a homing endonuclease variants, compositions, and methods of use ","Bluebird Bio, Inc.","Jordan JARJOUR, Jasdeep MANN",2016-07-25,2017-07-25,2019-05-29,,https://patents.google.com/patent/EP3487994A1/en,
WO-2017099712-A1,Improved t cell compositions ,"Bluebird Bio, Inc.",Kevin FRIEDMAN,2015-12-07,2015-12-07,2017-06-15,,https://patents.google.com/patent/WO2017099712A1/en,
WO-2017218519-A1,Gene therapy of neuronal ceroid lipofuscinoses ,"Bluebird Bio, Inc.","Kendrick A. GOSS, Geoffrey B. PARSONS, Asiya GINIATULLINA",2016-06-13,2017-06-13,2017-12-21,,https://patents.google.com/patent/WO2017218519A1/en,
WO-2018071565-A1,TCRa HOMING ENDONUCLEASE VARIANTS ,"Bluebird Bio, Inc.","Jordan JARJOUR, Mark POGSON",2016-10-11,2017-10-11,2018-04-19,,https://patents.google.com/patent/WO2018071565A1/en,
IS-9042-A,Compounds for improved viral transduction ,Bluebird Bio Inc,"Garrett Collins Heffner, Abraham Isaac Bassan",2014-04-03,2014-04-03,2014-04-03,,https://patents.google.com/patent/IS9042A/en,
WO-2019050841-A1,Hematopoietic stem cell compositions ,"Bluebird Bio, Inc., The Board Of Trustees Of The Leland Stanford Junior University","Ilya Shestopalov, Sean BENDALL, Luciene BORGES",2017-09-05,2018-09-04,2019-03-14,,https://patents.google.com/patent/WO2019050841A1/en,
WO-2018094244-A1,TGFβ SIGNAL CONVERTOR ,"Bluebird Bio, Inc.",Benjamin BOYERINAS,2016-11-17,2017-11-17,2018-05-24,,https://patents.google.com/patent/WO2018094244A1/en,
AU-2017346683-A1,"TGFßR2 endonuclease variants, compositions, and methods of use ","Bluebird Bio, Inc.","Kyle HAVENS, Jordan JARJOUR",2016-10-17,2017-10-17,2019-05-09,,https://patents.google.com/patent/AU2017346683A1/en,
CA-3034094-A1,"Il-10 receptor alpha homing endonuclease variants, compositions, and methods of use ","Bluebird Bio, Inc., Kyle HAVENS, Jordan JARJOUR","Kyle HAVENS, Jordan JARJOUR",2016-08-16,2017-08-15,2018-02-22,,https://patents.google.com/patent/CA3034094A1/en,
WO-2018218194-A1,"Variants de l'endonucléase cblb , compositions et procédés d'utilisation ","Bluebird Bio, Inc.","Jordan JARJOUR, Kyle HAVENS, Anne-Rachel KROSTAG",2017-05-25,2018-05-25,2018-11-29,,https://patents.google.com/patent/WO2018218194A1/fr,
